Benchling for Cell Therapy R&D

This application note outlines the critical needs and complexities of cell therapy R&D and how Benchling has helped address these challenges for leading cell therapy companies.


Cell therapies such as stem cells, CAR T cells, and TCR have been of significant interest in research over the past few decades. The FDA approval of CAR T therapies has led to renewed interest in the field. As companies rush to bring more novel cell therapies to the market, they face several R&D complexities.

This application note provides:

  • An outline of the complexities present in cell therapy research and development

  • How Benchling’s capabilities can solve these complexities

Download application note

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image